AWARE: A Phase 2 Multiple Dose, Multicentre, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ABBV-8E12 in Subjects with Early Alzheimer’s Disease.
Status: Active
Sponsor: AbbVie
DEMENTIA TRIALS AUSTRALIA
AWARE: A Phase 2 Multiple Dose, Multicentre, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ABBV-8E12 in Subjects with Early Alzheimer’s Disease.
Status: Active
Sponsor: AbbVie